Functional Proteomics Identifies Targets of Phosphorylation by B-Raf Signaling in Melanoma
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
SUMMARY Melanoma and other cancers harbor oncogenic mutations in the protein kinase B-Raf, which leads to constitutive activation and dysregulation of MAP kinase signaling. In order to elucidate molecular determinants responsible for B-Raf control of cancer phenotypes, we present a method for phosphoprotein profiling, using negative ionization mass spectrometry to detect phosphopeptides based on their fragment ion signature caused by release of PO3−. The method provides an alternative strategy for phosphoproteomics, circumventing affinity enrichment of phosphopeptides and isotopic labeling of samples. Ninety phosphorylation events were regulated by oncogenic B-Raf signaling, based on their responses to treating melanoma cells with MKK1/2 inhibitor. Regulated phosphoproteins included known signaling effectors and cytoskeletal regulators. We investigated MINERVA/FAM129B, a target belonging to a protein family with unknown category and function, and established the importance of this protein and its MAP kinase-dependent phosphorylation in controlling melanoma cell invasion into 3-dimensional collagen matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beausoleil, S. A., Villén, J., Gerber, S. A., Rush, J., & Gygi, S. P. (2006) · Nature Biotechnology · doi:10.1038/nbt1240 · Cited by 1,577
Mass spectrometry–based proteomics turns quantitative
Ong, S.-E., & Mann, M. (2005) · Nature Chemical Biology · doi:10.1038/nchembio736 · Cited by 1,572 · cited 1×
“To quantify changes in phosphorylation, metabolic labeling with isotopically distinguishable amino acids is a prevailing method (Ong and Mann, 2005).”
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371 · cited 6×
“Phosphorylated residues that were modulated by inhibition of MKK1/2 included known regulatory phosphorylation sites on ERK1, ERK2, RSK1 (p90-RSKa1), and RSK2 (p90-RSKa3) (Table 1).”
InfluentialSutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 1×
“…Eukaryotic translation initiation factor 4B P23588 RLPKpSPPYT S93 0.2 a, b 0 GSK3B Glycogen synthase kinase-3 beta P49841 PRTTpSFAES S9 0.7m a, b ND RSK2 Sutherland et al., 1993 NEDD4L E3 ubiquitin-protein ligase nedd4-like protein Q96PU5 PRSL[pS]SPTV [S448] 0.5 a, b 0 SGK Debonneville et al.,…”
InfluentialPhosphorylation of Nedd4‐2 by Sgk1 regulates epithelial Na+ channel cell surface expression
Debonneville, C., Flores, S. Y., Kamynina, E., Plant, P. J., Tauxe, C., Thomas, M. A., Münster, C., Chraïbi, A., Pratt, J. H., Horisberger, J., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7052 · Cited by 711 · cited 1×
“…PRTTpSFAES S9 0.7m a, b ND RSK2 Sutherland et al., 1993 NEDD4L E3 ubiquitin-protein ligase nedd4-like protein Q96PU5 PRSL[pS]SPTV [S448] 0.5 a, b 0 SGK Debonneville et al., 2001; Fouladkou et al., 2004 PAK4 p21-activated kinase 4 O96013 KRPLpSGPDV S181 0.0 b ND PCBP1 Poly(rC)-binding protein…”
InfluentialWang, W., Chen, J. X., Liao, R., Deng, Q., Zhou, J. J., Huang, S., & Sun, P. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3389-3403.2002 · Cited by 376 · cited 4×
“…Kinase Pathway MAPK1 MAP kinase, ERK2 P28482 TGFLpTEYVA T185 0.2 a, b + MEK1, JAK2, Cot Dang et al., 1998; Luciano et al., 2004; Walters et al., 2006; Wang et al., 2002 P28482 TGFLpTEpYVA T185;Y187 0.1 a, b + MEK1, JAK2, Cot Ibid MAPK3 MAP kinase, ERK1 P27361 TGFLpTEYVA T202 0.0 a, b + MEK1/2, Cot…”
InfluentialElevated expression of MITF counteracts B-RAF–stimulated melanocyte and melanoma cell proliferation
Wellbrock, C., & Marais, R. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505059 · Cited by 196 · cited 2×
“These include cyclin D1, Brn2, and microphthalmia-associated transcription factor (MITF), which modulate cell proliferation (Bhatt et al., 2005; Goodall et al., 2004; Wellbrock and Marais, 2005); and HIF1a, Bim1, and PUMA, which regulate cell survival against apoptotic cell stress (Wang et al.”
Cited by
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond
Holderfield, M., Deuker, M. M., McCormick, F., & McMahon, M. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3760 · Cited by 833
A Global Protein Kinase and Phosphatase Interaction Network in Yeast
Breitkreutz, A., Choi, H., Sharom, J. R., Boucher, L., Neduva, V., Larsen, B., Lin, Z.-Y., Breitkreutz, B.-J., Stark, C., Liu, G., et al. (2010) · Science · doi:10.1126/science.1176495 · Cited by 683
Decoding signalling networks by mass spectrometry-based proteomics
Choudhary, C., & Mann, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2900 · Cited by 571
Metadata
- Authors
- Old, W. M., Shabb, J. B., Houel, S., Wang, H., Couts, K. L., Yen, C.-Y., Litman, E. S., Croy, C. H., Meyer-Arendt, K., Miranda, J. G., Brown, R. A., Witze, E. S., Schweppe, R. E., Resing, K. A., & Ahn, N. G.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 34
- Issue
- 1
- Pages
- 115-131
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2038695324
- Cited by
- 136
- References
- 7
- FWCI
- 7.44
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.